PRZOOM - /newswire/ -
Amherst, NH, United States, 2011/01/31 - Greystone Research Associates analyzes device strategies, expanding therapeutic classes, and emerging indications.
Advances in drug formulation and inhalation device design are creating new opportunities for inhaled drug delivery as an alternative to oral and parenteral delivery methods. While several approaches for delivering active substances via oral inhalation compete in this space, dry powder inhalation (DPI) continues to attract investment in new combination product development and therapeutic indications at the expense of more established methods such as metered dose inhalers and nebulizers.
The rising potential of dry powder inhalation is being driven by research activity in powder formulations, advances in particle engineering, and the development of novel device architectures. The combination of improved particle properties and more efficient inhaler designs is creating new opportunities for dry powder inhalation and expanding the range of active compounds that can be effectively delivered to the lung via DPI.
“As aging population demographics and managed care initiatives drive growth in home health care and self-administration of drug therapies, inhaled medicine is increasingly being viewed as patient-friendly and cost-effective, ” explains George Perros, Greystone Research Managing Director. “Our analysis demonstrates that inhaled administration in general, and DPI in particular, are well positioned to take advantage of these trends and evolve into a significant factor in the future of pharmaceutical development and the commercialization of therapeutic drugs.”
These findings are contained in a new and comprehensive report, researched and prepared by Greystone Research Associates. Dry Powder Inhalation: Advancing Technology, Evolving Devices, Emerging Opportunities contains product and device assessments, pipeline analysis, market data, company profiles, forecasts and detailed analysis of key technology, regulatory and business factors.
Greystone Research Associates (greystoneassociates.org) is a medical technology consulting firm focused on the areas of medical market strategy, product commercialization, venture development, and market research. We assist medical and healthcare market participants in achieving their business objectives through the creation of detailed development strategies, product commercialization programs, and comprehensive market and technology research and analysis. Our market research publications are designed, researched and written to provide timely and insightful information and data on focused market segments, with the aim of providing market participants with the essential knowledge to refine and execute their marketing plans and financial targets.